Where Are Research Peptides Made? Supply Chains and “Made in Canada” Claims

The links in a peptide supply chain

A synthetic research peptide is built, not extracted. In solid-phase synthesis the sequence is “built up on a solid support”, in the words of the European Medicines Agency’s 2025 guideline on synthetic peptides; our explainer on how solid-phase synthesis works covers the chemistry. Five more links follow, and each can sit in a different company or country:

• Purification. The crude peptide is cleaved from the resin and, as the EMA guideline puts it, “generally purified using chromatographic techniques”.
• Isolation. The guideline calls freeze-drying (lyophilization) “common practice”, while precipitation, crystallization and spray drying are also used.
• Testing. A sample is analyzed and a report is issued for that lot.
• Filling and labelling. Vials receive a lot number, and material can later be repacked or relabelled by someone other than the maker.
• Distribution. The product moves to a seller, then to your lab.

An origin claim compresses that sequence of places into a word or two.

Where research peptides are made, and by whom

The chemistry at the start of the chain is specialist work, spread across the pharmaceutical industry and contract organizations that make peptides for others. A 2019 perspective in The Journal of Organic Chemistry on peptide synthesis and purification addresses that mix, encouraging synergies between academia, “the pharmaceutical industry, and contract research organizations/contract manufacturing organizations.”

Even one manufacturer may buy in parts of a molecule. For peptide medicines, the EMA asks for “the name and address of all starting material manufacturers” and notes that for conjugated peptides the linkers and conjugation moiety are, in many cases, made by a different manufacturer than the peptide. Those are medicine rules, cited only to show how many hands one molecule can pass through.

As for geography, we looked for an independent, published breakdown of where research-grade peptides are synthesized and found none; the commercial market-research reports we found estimate market size rather than document manufacturing sites. Origin therefore has to be established lot by lot, from what a seller can document, not assumed from where the seller is based.

What should travel with a lot

When several companies handle a peptide, paperwork holds the story together. The clearest description is in ICH Q7, the international good manufacturing practice guide for active pharmaceutical ingredients. Its section 17 covers “any party other than the original manufacturer” that trades, repacks, relabels, distributes or stores material, and says such parties “should maintain complete traceability”, keeping among other records:

• the original manufacturer’s identity and address;
• the manufacturer’s batch number;
• purchase, transport, receipt and distribution records;
• “All authentic Certificates of Analysis, including those of the original manufacturer”;
• the retest or expiry date.

When a certificate is reissued along the way, ICH Q7 says it should name “the laboratory that performed the analysis” and refer to the original manufacturer and to “the original batch Certificate, a copy of which should be attached.” The supplier should also give its customer “the name of the original API or intermediate manufacturer and the batch number(s) supplied”. The World Health Organization’s 2018 model certificate of analysis agrees: “A copy of the CoA generated by the original manufacturer should be attached.”

These are drug frameworks, and this article makes no claim about which rules apply to a laboratory reagent; they serve as a yardstick for complete documentation. For a research purchase, a practical minimum is a lot number that matches the certificate, a certificate that names the laboratory that did the work, and a way to trace any relabelled lot back to the original. Our guide to lot numbers and traceability explains what a matching number can and cannot prove.

What “Product of Canada” and “Made in Canada” mean

Origin claims on non-food products fall to the Competition Bureau, whose current enforcement guidelines, dated March 7, 2025, relate to the Competition Act, the Consumer Packaging and Labelling Act and the Textile Labelling Act. (Food origin labelling is a matter for the Canadian Food Inspection Agency.) The guidelines are not a licensing scheme — “we do not approve or certify such claims,” the Bureau says — but a statement of when it will generally not challenge one.

Both claims require that the last substantial transformation occurred in Canada. Goods are substantially transformed, the guidelines say, when they “undergo a fundamental change in form, appearance or nature such that the goods existing after the change are new and different goods”. The claims then differ on cost:

• “Product of Canada”: “all or virtually all (at least 98%)” of the total direct costs of producing or manufacturing the good incurred in Canada.
• “Made in Canada”: at least 51% of those costs incurred in Canada, plus a qualifying statement such as “Made in Canada with imported parts” or “Made in Canada with domestic and imported parts”.

How a claim is read matters as much as the arithmetic. The Bureau weighs “the general impression conveyed by a representation, as well as its literal meaning”, the rules cover every medium including the internet, and no one has to have been misled in fact. Misleading representations can be pursued criminally when made knowingly or recklessly (section 52 of the Competition Act) or as civil reviewable conduct (section 74.01).

Qualifiers are enforced. In December 2016 the Bureau resolved concerns over the parka maker Moose Knuckles’ “Made in Canada” advertising: the company agreed to make it clearer that certain parkas “are in fact made with Canadian and imported components” and to donate $750,000 over five years to charities in Canada.

The guidelines say nothing about chemicals or peptides, and this article applies them to no product. What the transformation test does make clear is the question to ask of any Canadian origin claim: which steps, from synthesis on, actually happened in Canada?

Canadian-owned, shipped from Canada, tested, formulated: different claims

Much Canadian wording is not, on its face, an origin claim; it describes the business, the warehouse or one process. Where a product meets neither test, the Bureau “recommends the use of a more specific term that more accurately reflects the limited production or manufacturing activity that took place in Canada”, and it accepts process claims such as “Designed in Canada” if they are accurate and understood as referring to that process.

Two rows can both be true of a business whose products are made abroad. “Shipped from Canada” says where the parcel begins its trip — our page on how orders ship within Canada describes ours — and nothing about the contents. “Canadian-owned” says who owns the company. The risk is context: the Bureau reads implied claims through “the overall general impression” of an advertisement, label or other promotional material, so a maple leaf beside “Canadian-owned” can say more than the words do.

Questions to ask any supplier about origin

Each of these needs more than a slogan:

1. “What does your Canadian wording refer to?” Ownership, shipping, one process or manufacture. A good answer names the step.
2. “Were synthesis, purification and freeze-drying done by one manufacturer?” If not, ask how your lot number connects to the original batch.
3. “Has this material been repacked or relabelled?” If so, the documents should still lead back to the original batch.
4. “Who tested this lot, and does the report carry my vial’s lot number?” A certificate is evidence about the lot it names, and nothing more.
5. “If you reissued the certificate, does it name the testing laboratory?” ICH Q7 and the WHO model both expect that.

If a supplier declines to name its manufacturer, the documentation for your lot has to carry more of the weight. We are a supplier too, so put the same questions to us; our guide to choosing a Canadian supplier turns them into a wider checklist.

What’s established and what isn’t

Origin and sourcing questions in Canada

Origin is now a practical question for Canadian labs. The Tri-agency Guide on Financial Administration, in effect from April 1, 2026, says institutions and grant recipients “are strongly encouraged to take reasonable steps to prioritize Canadian suppliers, services, material and content wherever possible.” Supplier and material are different words there, and the federal government keeps them apart in its own buying: its Buy Canadian materials policy for large construction and defence purchases says “materials must be made in Canada, not simply sold by Canadian companies”. How your institution reads that wording is its decision, not a supplier’s.

Our own facts: Pure Peptides Canada is a Canadian-owned online supplier of research peptides and laboratory reagents, established in 2023 and based in Toronto. We price in Canadian dollars and ship tracked from inside Canada to every province and territory. As our guide to research peptides in Canada states, our research peptides are made “by specialist peptide manufacturers overseas”.

For anything specific to a product or lot — the question no origin label can answer — ask us directly.

Our research peptides and their batch documents

Janoshik test reports for the research peptides below are listed on our Lab Testing page. If you need more detail about a particular lot before you order, ask us through the Contact page.

BPC-15715-amino-acid research peptideView product GHK-CuCopper tripeptideView product TB-500Thymosin beta-4 research peptideView product KPVLys-Pro-Val tripeptideView product

Frequently asked questions